<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS134144</article-id>
<article-id pub-id-type="doi">10.1101/2021.08.22.457295</article-id>
<article-id pub-id-type="archive">PPR387109</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Intra-host SARS-CoV-2 evolution in the gut of mucosally-infected <italic>Chlorocebus aethiops</italic> (African green monkeys)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Rowe</surname>
<given-names>Lori A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Beddingfield</surname>
<given-names>Brandon J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goff</surname>
<given-names>Kelly</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Killeen</surname>
<given-names>Stephanie Z.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chirichella</surname>
<given-names>Nicole R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melton</surname>
<given-names>Alexandra</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roy</surname>
<given-names>Chad J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maness</surname>
<given-names>Nicholas J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Tulane National Primate Research Center, Covington, LA</aff>
<aff id="A2">
<label>2</label>Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Corresponding author; <email>nmaness@tulane.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>08</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>29</day>
<month>08</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">In recent months, several SARS-CoV-2 variants have emerged that enhance transmissibility and escape host humoral immunity. Hence, the tracking of viral evolutionary trajectories is clearly of great importance. Little is known about SARS-CoV-2 evolution in nonhuman primate models used to test vaccines and therapies and to model human disease. Viral RNA was sequenced from rectal swabs from <italic>Chlorocebus aethiops</italic> (African green monkeys) after experimental respiratory SARS-CoV-2 infection. Two distinct patterns of viral evolution were identified that were shared between all collected samples. First, mutations in the furin cleavage site that were initially present in the virus as a consequence of VeroE6 cell culture adaptation were subsequently lost in virus recovered in rectal swabs, confirming the necessity of this motif for viral infection <italic>in vivo</italic>. Three amino acid changes were also identified; ORF 1a S2103F, and spike D215G and H655Y, that were detected in rectal swabs from all sampled animals. These findings are demonstrative of intra-host SARS-CoV-2 evolution unique to this nonhuman primate species and may identify a host-adapted variant of SARS-CoV-2 that would be useful in future development of primate disease models.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has killed more than 4 million people to date. Despite the development and rollout of safe and highly effective vaccines on an unparalleled time scale, nearly unchecked viral spread has continued due to vaccine refusal and hesitancy in nations with adequate vaccine supply coupled with inadequate supply in many regions of the world. As a result, several new variants have emerged with enhanced replicative or infectious capacity and immune escape [<xref ref-type="bibr" rid="R1">1</xref>]. Since the discovery of the D614G mutation [<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref>], noted early in the pandemic and found to enable enhanced infection in cells and is now present in all sequenced isolates, several variants of interest and concern (as defined by the CDC) have arisen [<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R11">11</xref>]. These include B.1.1.7 (alpha), which was originally detected in the United Kingdom and rapidly spread globally, B.1.351 (beta), originally detected in South Africa, and P.1 (gamma), originally detected in Japan in a traveler from Brazil. Most recently, the B.1.617.2 (delta) variant has rapidly become globally dominant, which is of great concern due to its greatly enhanced transmissibility relative to other variants and its ability to infect vaccinated individuals [<xref ref-type="bibr" rid="R12">12</xref>]. Collectively, these data suggest a concerning scenario wherein there is an ample ontological niche for continued SARS-CoV-2 evolution to facilitate persistence and pandemic spread in populations, including those with preexisting immunity to the virus.</p>
<p id="P3">Several animal species have been tested in efforts to develop a disease model that faithfully recapitulates human disease and associated pathological consequence, ultimately to be used in the evaluation of promising vaccines and therapies for COVID-19. Multiple nonhuman primate (NHP) species have been explored to this end, including <italic>Macaca mulatta</italic> (rhesus macaque) (RhM), <italic>Papio anubis</italic> (baboons) [<xref ref-type="bibr" rid="R13">13</xref>], <italic>Macaca nemestrina</italic> (pigtail macaques) (manuscript in preparation), <italic>Macaca fascicularis</italic> (cynomolgus macaque), and <italic>Chlorocebus aethiops</italic> (African green monkeys; AGM) [<xref ref-type="bibr" rid="R14">14</xref>–<xref ref-type="bibr" rid="R16">16</xref>]. Although some data suggest enhanced disease in AGM relative to other species [<xref ref-type="bibr" rid="R17">17</xref>], SARS-CoV-2 replicates to high titer in all of these species. However, in most cases, viral replication in upper respiratory sites is restricted to the first several days after infection. Thus, detection of intrahost evolution in these sites may be limited. Importantly, it is now becoming clear that the virus can persist and continue to replicate in gastrointestinal sites [<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref>], which provides an opportunity to examine viral evolution beyond the first several days of infection and may illuminate tissue-specific compartmentalized evolution.</p>
<p id="P4">In this study, a focused set of gastrointestinal samples was used to examine viral and host dynamics in SARS-CoV-2 infected African green monkeys (AGM). Consistent patterns of evolution were identified, which is suggestive of species-specific adaptation. The samples were exclusively rectal swabs, which suggest viral replication in the gastrointestinal system may be an important source of viral variants. Notably, these results have important implications for the detection of SARS-CoV-2 variants in wastewater [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>].</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S3">
<title>Sample collection, RNA Isolation and conversion to cDNA</title>
<p id="P5">Rectal Swabs were collected and stored in RNA/DNA Shield (Zymo Reseach, Irvine, CA). RNA was isolated using the Zymo Quick-RNA Viral kit and converted to cDNA using Protoscript II (New England Biolabs, Ipswich, MA) as follows: 10μl Template RNA, 1μl 10μM random hexamers, and 1μl 10mM dNTPs were incubated at 65°C for 5 minutes and then place directly on ice for 1 minute. The following was then added: 4μl PSII buffer, 2μl 100mM DTT, 1μl RNase inhibitor, and 1μl PSII reverse transcriptase and incubated at 42°C for 50 minutes, then 70°C for 10 minutes, followed by a hold at 4°C.</p>
</sec>
<sec id="S4">
<title>Sequencing</title>
<p id="P6">DNA libraries were made using the standard SWIFT Normalase Amplicon Panels protocol (SWIFT Biosciences, Ann Arbor, MI) utilizing the SNAP UD indexing primers. The libraries were normalized to 4nM and pooled. Paired-end sequencing (2 × 150) was performed on the Illumina (San Diego, CA) MiSeq platform.</p>
</sec>
<sec id="S5">
<title>Data analysis</title>
<p id="P7">Primer sequences were trimmed, and sequence reads were aligned to the SARS-CoV-2 genome (WA1/2020 isolate, accession MN985325) using the built-in mapping function in Geneious Prime software. Variants were called that were present at greater than 10% of reads at that site. Variants detected in the SARS-CoV-2 spike structure were visualized with UCSF Chimera, developed by the Resources for Biocomputing, Visualization, and Informatics at the University of California, San Francisco [<xref ref-type="bibr" rid="R22">22</xref>].</p>
</sec>
</sec>
<sec id="S6" sec-type="results | discussion">
<title>Results and Discussion</title>
<p id="P8">A high-density overlapping amplicon approach was used to amplify and sequence the entire SARS-CoV-2 genome from the viral stock used to experimentally infect the AGM. Rectal swabs isolated from three AGM infection at 3-4 weeks post infection were interrogated in the same fashion. The challenge stock harbored several mutations of various frequencies relative to the WA1/2020 patient isolate (<xref ref-type="fig" rid="F1">Figure 1A</xref>). These included two mutations in spike, F79L and a high frequency mutation that changed the arginine (R) at position 682 to a leucine (R682L) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). This residue is the second arginine, and one of the key residues, in the RRAR furin cleavage site, most likely the result of adaptation to VeroE6 cells. This stock was used to infect three AGMs from which samples were available. Samples were acquired from nasal, oropharyngeal, and rectal swabs from time points spanning four weeks postinfection. RNA extracted from swabs at early time points were exhausted from extensive qRT PCR characterization and focus was shifted to rectal swabs collected from late time points including 21 and 28 days post infection in three of the AGMs. Sequencing of these samples revealed a consistent pattern of evolution <italic>in vivo</italic> with three mutations arising in all three animals; ORF1a/b S2103F, spike D215G and spike H655Y (<xref ref-type="fig" rid="F1">Figure 1B</xref>). In contrast, F79L and R682L mutations, present at approximately 60 and 80% in the virus stock, respectively, were completely absent in all rectal samples.</p>
<p id="P9">The ORF1a/b residue 2103 lies in nonstructural protein 3 (nsp3), which is the largest protein in the SARS-CoV-2 proteome and localizes with other viral proteins to the cell membrane [<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. The S2103F mutation in this protein has been detected at low frequency in human samples including in India [<xref ref-type="bibr" rid="R25">25</xref>], but is not restricted to a particular clade and through the course of the pandemic has never been detected in greater than 1% of all sequenced isolates (nextstrain.org [<xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref>]).</p>
<p id="P10">The R682L mutation likely eliminates the furin cleavage site in spike. Reversion to the wild type amino acid, therefore, confirms the necessity of the furin cleavage site for infection <italic>in vivo</italic>, which has been previously suggested [<xref ref-type="bibr" rid="R28">28</xref>]. This finding, although not unexpected but noteworthy, confirms that the loss of the furin cleavage site <italic>in vitro</italic> can be ascribed to replication in VeroE6 cells [<xref ref-type="bibr" rid="R29">29</xref>]. Since VeroE6 cells are sourced from AGM kidney, this finding confirms the loss of the furin cleavage site to be an <italic>in vitro</italic> phenomenon and not specific to replication in AGM cells <italic>per se</italic>. The D215G mutation rose from approximately 15% prevalence in the stock to near 100% in all three animals. This mutation lies in the N-terminal domain of the spike protein (<xref ref-type="fig" rid="F1">Figure 1C</xref>) and is detected at low frequency in multiple viral lineages and is a defining variant of the B.1.351 (beta) lineage (nextstrain.org). One report showed this mutation has a weak but detectable impact on augmenting cell to cell fusion [<xref ref-type="bibr" rid="R30">30</xref>]. The H655Y mutation which lies immediately adjacent to the furin cleavage site (<xref ref-type="fig" rid="F1">Figure 1C</xref>) and has been detected sporadically in multiple viral lineages with the P.1 (gamma) lineage being most prominent as H655Y is a defining variant of the gamma lineage (nextstrain.org). This variant has also been detected in other animal species disease models including cats and mink [<xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref>]. A recent report also showed that virus harboring a 655Y amino acid showed enhanced replicative capacity <italic>in vitro</italic> and spike protein cleavage [<xref ref-type="bibr" rid="R32">32</xref>], likely explaining the H655Ymutation in the AGM species.</p>
<p id="P11">In this study, we define a consistent pattern of viral evolution in SARS-CoV-2-infected AGM. Despite a limited sample size, the ubiquity with which this pattern was detected strongly suggests a selective advantage to the identified mutations. All samples used in this study were derived from rectal rather than respiratory samples, and the data do not clearly suggest a possible mechanism for this selection. It is plausible that replication in the GI tract presents a unique set of selective forces on the virus driving evolution to the mutations identified. Long-term persistence of the virus in the gastrointestinal tract, as has been suggested for SARS-CoV-2 in humans and is a well-described phenomenon in other coronaviruses [<xref ref-type="bibr" rid="R33">33</xref>] may also allow selected mutations to accumulate. Even in the latter case, these data suggest the virus continues to replicate and evolve throughout the gastrointestinal system, which may further reveal novel aspects of the virus-host relationship and may have important implications for the detection of variants in wastewater.</p>
</sec>
<sec id="S7" sec-type="conclusions">
<title>Conclusions</title>
<p id="P12">These data and study support two important conclusions. First, previous reports that an intact furin cleavage site is important for infection <italic>in vivo</italic> were confirmed in this study. Second, the combination of the three mutations identified (ORF1a/b S2103F, spike D215G and spike H655Y) represents a new host-adapted SARS-CoV-2 strain exclusive to the AGM species. Future experiments may include infection of AGM (or other nonhuman primate species) with this virus to optimize infectious challenge in product evaluation or immunopathogenesis studies. Alternatively, these mutations could be added to the backbone of variants of concern to assess their impact on experimental infection in AGM or other closely related nonhuman primate species.</p>
</sec>
</body>
<back>
<ack id="S8">
<title>Funding</title>
<p>This work was supported by NIH/NIAID contract HHSN27220170033I (CJR) and grant P51OD01110459, the TNPRC base grant.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P13">
<bold>Author contributions</bold>
</p>
<p id="P14">LAR, BJB, CJR, and NJM conceived and designed the experiments. LAR, BJB, KG, SZK, NRC, and AM performed the experiments and assisted with sample manipulation. NJM and CJR drafted the manuscript. All authors have read and agreed to the current version of the manuscript.</p>
</fn>
<fn id="FN2">
<p id="P15">
<bold>Institutional Animal Care and Use Statement</bold>
</p>
<p id="P16">The use of nonhuman primates in this project was reviewed and approved by the Tulane Institutional Animal Care and Use Committee (IACUC), protocol P0447.</p>
</fn>
</fn-group>
<ref-list>
<title>Bibliography</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caspari</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The Spike of Concern-The Novel Variants of SARS-CoV-2</article-title>
<source>Viruses</source>
<year>2021</year>
<volume>13</volume>
<pub-id pub-id-type="doi">10.3390/v13061002</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ojha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Rangarajan</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vanderheiden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Suthar</surname>
<given-names>MS</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1038/S41467-020-19808-4</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Theiler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abfalterer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hengartner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giorgi</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<fpage>812</fpage>
<lpage>827</lpage>
<elocation-id>e19</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.06.043</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>VanBlargan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Errico</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies</article-title>
<source>Res Sq</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.21203/rs.3.rs-228079/v1</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McMahan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tostanoski</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Aid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jacob-Dolan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anioke</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera</article-title>
<source>J Virol</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1128/JVI.00404-21</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Niemcewicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Podogrocki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Majsterek</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bijak</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The Emerging Concern and Interest SARS-CoV-2 Variants</article-title>
<source>Pathogens</source>
<year>2021</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.3390/pathogens10060633</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akkiz</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development</article-title>
<source>Front Med</source>
<year>2021</year>
<volume>8</volume>
<elocation-id>636532</elocation-id>
<pub-id pub-id-type="doi">10.3389/fmed.2021.636532</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Focosi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines</article-title>
<source>Rev Med Virol</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1002/rmv.2231</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shamier</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Bogers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>den Hartog</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gommers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nieuwkoop</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Rijsbergen</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>van Osch</surname>
<given-names>JAT</given-names>
</name>
<name>
<surname>Dijkhuizen</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees</article-title>
<source>Sci Immunol</source>
<year>2021</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.1126/sciimmunol.abj1750</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCallum</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Marco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lempp</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Tortorici</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walls</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Beltramello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zatta</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2</article-title>
<source>Cell</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2021.03.028</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tegally</surname>
<given-names>H</given-names>
</name>
<name>
<surname>San</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Shank</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Giandhari</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Naidoo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pillay</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape</article-title>
<source>medRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.02.23.21252268</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puranik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lenehan</surname>
<given-names>PJ</given-names>
<suffix>1+</suffix>
</name>
<name>
<surname>Silvert</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Niesen</surname>
<given-names>MJM</given-names>
</name>
<name>
<surname>Corchado-Garcia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O’horo</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Virk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Swift</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Halamka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Badley</surname>
<given-names>AD</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence</article-title>
<pub-id pub-id-type="doi">10.1101/2021.08.06.21261707</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ganatra</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Gazi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thippeshappa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alfson</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Clemmons</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Escobedo</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets</article-title>
<source>Nat Microbiol</source>
<year>2021</year>
<volume>6</volume>
<fpage>73</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1038/s41564-020-00841-4</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blair</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Vaccari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doyle-Meyers</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Russell-Lodrigue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fahlberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monjure</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Beddingfield</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques</article-title>
<source>Am J athol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2020.10.016</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munster</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>van Doremalen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Perez-Perez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meade-White</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Okumura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Callison</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brumbaugh</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Respiratory disease in rhesus macaques inoculated with SARS-CoV-2</article-title>
<source>Nature</source>
<year>2020</year>
<volume>585</volume>
<fpage>268</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2324-7</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finch</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Crozier</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Byrum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sharer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sayre</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kocher</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (&lt;em&gt;Macaca fascicularis&lt;/em&gt;)</article-title>
<source>bioRxiv</source>
<year>2020</year>
<elocation-id>2020.05.14.096727</elocation-id>
<pub-id pub-id-type="doi">10.1101/2020.05.14.096727</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blair</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Vaccari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doyle-Meyers</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Russell-Lodrigue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fahlberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monjure</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Beddingfield</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques</article-title>
<source>Am J Pathol</source>
<year>2021</year>
<volume>191</volume>
<fpage>274</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2020.10.016</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaebler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>JCC</given-names>
</name>
<name>
<surname>Muecksch</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Finkin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tokuyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jankovic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schaefer-Babajew</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>TY</given-names>
</name>
<etal/>
</person-group>
<article-title>Evolution of antibody immunity to SARS-CoV-2</article-title>
<source>Nature</source>
<year>2021</year>
<volume>591</volume>
<fpage>639</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-021-03207-w</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartman</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Nambulli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McMillen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>White</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Tilston-Lunel</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Albe</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cottle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>James Frye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>TH</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts</article-title>
<source>PLoS Pathog</source>
<year>2020</year>
<volume>16</volume>
<pub-id pub-id-type="doi">10.1371/JOURNAL.PPAT.1008903</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wannigama</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Amarasiri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Phattharapornjaroen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hongsing</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Saethang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Luk-In</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Tracking COVID-19 with wastewater to understand asymptomatic transmission</article-title>
<source>Int J Infect Dis</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1016/j.ijid.2021.05.005</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mindermann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Whittaker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mellan</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Wilton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Klapsa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mate</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fritzsche</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zambon</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England</article-title>
<source>EClinicalMedicine</source>
<year>2021</year>
<volume>39</volume>
<elocation-id>101064</elocation-id>
<pub-id pub-id-type="doi">10.1016/J.ECLINM.2021.101064</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pettersen</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Couch</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Greenblatt</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Ferrin</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title>
<source>J Comput Chem</source>
<year>2004</year>
<volume>25</volume>
<fpage>1605</fpage>
<lpage>1612</lpage>
<pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuman</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Saikatendu</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klaus</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Wüthrich</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3</article-title>
<source>J Virol</source>
<year>2008</year>
<volume>82</volume>
<fpage>5279</fpage>
<lpage>5294</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02631-07</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kusov</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hilgenfeld</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein</article-title>
<year>2017</year>
<pub-id pub-id-type="doi">10.1016/j.antiviral.2017.11.001</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mallick</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Title: SARS-CoV-2 has observably higher propensity to accept uracil as nucleotide 1 substitution: Prevalence of amino acid substitutions and their predicted functional 2 implications in circulating SARS-CoV-2 in India up to</article-title>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.10.07.329771</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sagulenko</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Puller</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>TreeTime: Maximum-likelihood phylodynamic analysis</article-title>
<pub-id pub-id-type="doi">10.1093/ve/vex042</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadfield</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Megill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Huddleston</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Callender</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sagulenko</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bedford</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Nextstrain: real-time tracking of pathogen evolution</article-title>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bty407</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kalveram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Muruato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Juelich</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JK</given-names>
</name>
<etal/>
</person-group>
<article-title>Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis</article-title>
<source>Nature</source>
<year>2021</year>
<volume>591</volume>
<fpage>293</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-021-03237-4</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klimstra</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Tilston-Lunel</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Nambulli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boslett</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McMillen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.19.154930</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael Rajah</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hubert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grzelak</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Planas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dufloo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gellenoncourt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zivaljic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Planchais</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation 2 3</article-title>
<pub-id pub-id-type="doi">10.1101/2021.06.11.448011</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Halfmann</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hodcroft</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Weiler</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Haj</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Hatta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck</article-title>
<source>PLoS Pathog</source>
<year>2021</year>
<volume>17</volume>
<pub-id pub-id-type="doi">10.1371/JOURNAL.PPAT.1009373</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escalera</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gonzalez-Reiche</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Aslam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mena</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pearl</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Laporte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fossati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rathnasinghe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alshammary</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van de Guchte</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 variants of concern have acquired mutations associated with an 1 increased spike cleavage 2 3</article-title>
<pub-id pub-id-type="doi">10.1101/2021.08.05.455290</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kenney</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Vlasova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Saif</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Naturally Occurring Animal Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease</article-title>
<pub-id pub-id-type="doi">10.1177/0300985820980842</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>Jette</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Abernathy</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Dam</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Esswein</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Gristick</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Malyutin</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Sharaf</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Huey-Tubman</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YE</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies</article-title>
<source>Nature</source>
<year>2020</year>
<volume>588</volume>
<fpage>682</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-020-2852-1</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Viral evolution detected in rectal swabs in SARS-CoV-2 infected AGM. AGM were challenged via intranasal and intratracheal route with SARS-CoV-2 using a stock of the WA1/2020 isolate harboring several variants relative to the patient sample (A). Sequencing of viral RNA isolated from rectal swabs at 3-4 weeks after challenge revealed a consistent pattern of variants in all three animals (B). Two spike mutations detected in all animals map to the N-terminal domain (D215G) and near the furin cleavage site (H655Y) based on a spike structure (PBD 7K8Z [<xref ref-type="bibr" rid="R34">34</xref>]) (C).</p>
</caption>
<graphic xlink:href="EMS134144-f001"/>
</fig>
</floats-group>
</article>
